• Something wrong with this record ?

Dynamic contrast-enhanced magnetic resonance imaging as a tool to monitor the blood supply to an artificial cavity used as a site for islet transplantation in rats

J. Kriz, D. Jirak, T. Koblas, G. Vilk, P. Girman, M. Hajek, F. Saudek,

. 2011 ; 43 (9) : 3226-30.

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't

BACKGROUND: The transplantation of islets of Langerhans isolated from one donor pancreas can rarely release a diabetic recipient from insulin injections. The major reason is the destruction of 50%-60% of the transplanted tissue, which proceeds typically within a few hours after the insertion of the islets into the portal vein. Therefore, several groups have focused on development of an artificial site for islet transplantation. The main aim of the present study was to test the efficacy of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to evaluate the blood supply feeding the artificially created cavities for islet transplantation. METHODS: Two rounded devices were implanted: one device subcutaneously and the second one into the greater omentum of each animal. On the day of implantation as well as 1, 3, and 4 weeks later, we quickly injected the vascular specific MR contrast agent Vasovist (0.05 mL/100 g) intravenously. Penetration of the contrast agent was monitored by DCE-MRI. The influence of the contrast agent on the signal intensity observed within selected target areas was calculated with the use of ImageJ software. RESULTS: The penetration of the contrast agent was detected by the increase in signal intensity within implanted devices. The signal increase caused by the contrast compound was normalized to kidney tissue. On day of implantation of the device, no signal due to the contrast agent was detected in all devices. However, over the following weeks, there was an increase in signal detection within the omental device to 34%, 21%, and 14% of that of the kidney. Within the subcutaneously implanted devices there was an increase in signal detection up to 11%, 10%, and 7% of that detected in the kidney. CONCLUSIONS: The optimal time for transplantation of pancreatic islets into our omental device was 1 week after implantation of the scaffold. Also, the blood supply feeding the subcutaneous devices was regarded to be inadequate.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008653
003      
CZ-PrNML
005      
20150401101530.0
007      
ta
008      
150306s2011 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.transproceed.2011.09.012 $2 doi
035    __
$a (PubMed)22099763
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Kriz, J $u Diabetes Center, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. jkri@ikem.cz
245    10
$a Dynamic contrast-enhanced magnetic resonance imaging as a tool to monitor the blood supply to an artificial cavity used as a site for islet transplantation in rats / $c J. Kriz, D. Jirak, T. Koblas, G. Vilk, P. Girman, M. Hajek, F. Saudek,
520    9_
$a BACKGROUND: The transplantation of islets of Langerhans isolated from one donor pancreas can rarely release a diabetic recipient from insulin injections. The major reason is the destruction of 50%-60% of the transplanted tissue, which proceeds typically within a few hours after the insertion of the islets into the portal vein. Therefore, several groups have focused on development of an artificial site for islet transplantation. The main aim of the present study was to test the efficacy of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) to evaluate the blood supply feeding the artificially created cavities for islet transplantation. METHODS: Two rounded devices were implanted: one device subcutaneously and the second one into the greater omentum of each animal. On the day of implantation as well as 1, 3, and 4 weeks later, we quickly injected the vascular specific MR contrast agent Vasovist (0.05 mL/100 g) intravenously. Penetration of the contrast agent was monitored by DCE-MRI. The influence of the contrast agent on the signal intensity observed within selected target areas was calculated with the use of ImageJ software. RESULTS: The penetration of the contrast agent was detected by the increase in signal intensity within implanted devices. The signal increase caused by the contrast compound was normalized to kidney tissue. On day of implantation of the device, no signal due to the contrast agent was detected in all devices. However, over the following weeks, there was an increase in signal detection within the omental device to 34%, 21%, and 14% of that of the kidney. Within the subcutaneously implanted devices there was an increase in signal detection up to 11%, 10%, and 7% of that detected in the kidney. CONCLUSIONS: The optimal time for transplantation of pancreatic islets into our omental device was 1 week after implantation of the scaffold. Also, the blood supply feeding the subcutaneous devices was regarded to be inadequate.
650    _2
$a zvířata $7 D000818
650    _2
$a biokompatibilní materiály $7 D001672
650    _2
$a kontrastní látky $x farmakologie $7 D003287
650    _2
$a experimentální diabetes mellitus $x patologie $7 D003921
650    _2
$a gadolinium $x farmakologie $7 D005682
650    _2
$a intravenózní infuze $7 D007262
650    _2
$a Langerhansovy ostrůvky $x cytologie $7 D007515
650    _2
$a transplantace Langerhansových ostrůvků $x metody $7 D016381
650    _2
$a ledviny $x metabolismus $7 D007668
650    _2
$a magnetická rezonanční tomografie $x metody $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a organokovové sloučeniny $x farmakologie $7 D009942
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a software $7 D012984
650    _2
$a časové faktory $7 D013997
650    _2
$a tkáňové podpůrné struktury $7 D054457
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Jirak, D
700    1_
$a Koblas, T
700    1_
$a Vilk, G
700    1_
$a Girman, P
700    1_
$a Hajek, M
700    1_
$a Saudek, F
773    0_
$w MED00004556 $t Transplantation proceedings $x 1873-2623 $g Roč. 43, č. 9 (2011), s. 3226-30
856    41
$u https://pubmed.ncbi.nlm.nih.gov/22099763 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150401101800 $b ABA008
999    __
$a ok $b bmc $g 1065926 $s 891453
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 43 $c 9 $d 3226-30 $i 1873-2623 $m Transplantation proceedings $n Transplant Proc $x MED00004556
LZP    __
$a Pubmed-20150306

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...